[
  {
    "objectID": "quarto/index.html",
    "href": "quarto/index.html",
    "title": "Outcomes in HFrEF vs HFpEF in Patients with Iron Deficiency Anemia",
    "section": "",
    "text": "Data Source: Cross-sectional analysis of the National Inpatient Sample (NIS) from 2018 to 2020.\nPatient Selection: Included all inpatient admissions with Iron deficiency anemia.\nHF Categories:\n\nHeart failure with reduced ejection fraction\nHeart failure with preserved ejection fraction\n\nICD Codes:\n\nHFrEF = I50.2 and I50.4\nHFpEF = I50.3\n\nPrimary Outcomes:\n\nIn-hospital all-cause mortality\nTotal hospital length of stay (days)\nTotal charge, inflation adjusted to 2020 ($)\n\nSoftware: All analyses were performed using R Version 4.4.1 (R Foundation for Statistical Computing, Vienna, Austria)"
  },
  {
    "objectID": "quarto/index.html#preamble",
    "href": "quarto/index.html#preamble",
    "title": "Outcomes in HFrEF vs HFpEF in Patients with Iron Deficiency Anemia",
    "section": "",
    "text": "Data Source: Cross-sectional analysis of the National Inpatient Sample (NIS) from 2018 to 2020.\nPatient Selection: Included all inpatient admissions with Iron deficiency anemia.\nHF Categories:\n\nHeart failure with reduced ejection fraction\nHeart failure with preserved ejection fraction\n\nICD Codes:\n\nHFrEF = I50.2 and I50.4\nHFpEF = I50.3\n\nPrimary Outcomes:\n\nIn-hospital all-cause mortality\nTotal hospital length of stay (days)\nTotal charge, inflation adjusted to 2020 ($)\n\nSoftware: All analyses were performed using R Version 4.4.1 (R Foundation for Statistical Computing, Vienna, Austria)"
  },
  {
    "objectID": "quarto/index.html#baseline-table",
    "href": "quarto/index.html#baseline-table",
    "title": "Outcomes in HFrEF vs HFpEF in Patients with Iron Deficiency Anemia",
    "section": "Baseline Table:",
    "text": "Baseline Table:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nHeart failure with preserved ejection fraction\nN = 520,8851\nHeart failure with reduced ejection fraction\nN = 425,4051\np-value2\n\n\n\n\nAge, y\n73 (13)\n70 (14)\n&lt;0.001\n\n\nSex\n\n\n\n\n&lt;0.001\n\n\n    Female\n330,210 (63%)\n186,740 (44%)\n\n\n\n\n    Male\n190,655 (37%)\n238,655 (56%)\n\n\n\n\nRace\n\n\n\n\n&lt;0.001\n\n\n    White\n354,990 (70%)\n258,350 (62%)\n\n\n\n\n    Asian or Pacific Islander\n10,010 (2.0%)\n8,290 (2.0%)\n\n\n\n\n    Black\n94,210 (18%)\n100,970 (24%)\n\n\n\n\n    Hispanic\n37,305 (7.3%)\n35,570 (8.5%)\n\n\n\n\n    Native American\n3,025 (0.6%)\n2,855 (0.7%)\n\n\n\n\n    Other\n10,755 (2.1%)\n10,390 (2.5%)\n\n\n\n\nElixhauser comorbidity index\n7.94 (1.98)\n7.91 (2.03)\n0.001\n\n\nResidential income\n\n\n\n\n&lt;0.001\n\n\n    $1 - $51,999\n160,825 (31%)\n146,185 (35%)\n\n\n\n\n    $52,000 - $65,999\n137,745 (27%)\n111,610 (27%)\n\n\n\n\n    $66,000 - $87,999\n121,180 (24%)\n92,425 (22%)\n\n\n\n\n    $88,000 or more\n94,155 (18%)\n67,050 (16%)\n\n\n\n\nExpected primary payer\n\n\n\n\n&lt;0.001\n\n\n    Private\n58,710 (11%)\n61,025 (14%)\n\n\n\n\n    Medicaid\n42,755 (8.2%)\n54,060 (13%)\n\n\n\n\n    Medicare\n411,755 (79%)\n301,790 (71%)\n\n\n\n\n    Other\n7,275 (1.4%)\n8,100 (1.9%)\n\n\n\n\nHospital region\n\n\n\n\n&lt;0.001\n\n\n    Midwest\n148,350 (28%)\n113,875 (27%)\n\n\n\n\n    Northeast\n102,585 (20%)\n72,805 (17%)\n\n\n\n\n    South\n190,475 (37%)\n164,665 (39%)\n\n\n\n\n    West\n79,475 (15%)\n74,060 (17%)\n\n\n\n\nHypertension\n42,155 (8.1%)\n29,455 (6.9%)\n&lt;0.001\n\n\nHyperlipidemia\n299,290 (57%)\n240,825 (57%)\n&lt;0.001\n\n\nPeripheral vascular disease\n67,155 (13%)\n102,640 (24%)\n&lt;0.001\n\n\nChronic obstructive pulmonary disease\n234,725 (45%)\n159,285 (37%)\n&lt;0.001\n\n\nCoronary artery disease\n220,005 (42%)\n240,850 (57%)\n&lt;0.001\n\n\nDementia\n53,610 (10%)\n35,555 (8.4%)\n&lt;0.001\n\n\nFluid and electrolyte imbalance\n253,820 (49%)\n209,790 (49%)\n0.013\n\n\nValvular heart disease\n70,515 (14%)\n61,135 (14%)\n&lt;0.001\n\n\nAtrial fibrillation\n198,540 (38%)\n160,570 (38%)\n0.11\n\n\nObesity\n156,735 (30%)\n92,240 (22%)\n&lt;0.001\n\n\nPresence of pacemaker\n44,780 (8.6%)\n82,540 (19%)\n&lt;0.001\n\n\nprevious MI\n56,800 (11%)\n83,995 (20%)\n&lt;0.001\n\n\nPior cardiac surgery\n70,565 (14%)\n77,805 (18%)\n&lt;0.001\n\n\nMalnutrition\n49,315 (9.5%)\n47,560 (11%)\n&lt;0.001\n\n\nCancer\n31,260 (6.0%)\n25,995 (6.1%)\n0.3\n\n\n\n1 Mean (SD); n (%)\n\n\n2 Design-based KruskalWallis test; Pearson’s X^2: Rao & Scott adjustment"
  },
  {
    "objectID": "quarto/index.html#outcomes-table",
    "href": "quarto/index.html#outcomes-table",
    "title": "Outcomes in HFrEF vs HFpEF in Patients with Iron Deficiency Anemia",
    "section": "Outcomes Table:",
    "text": "Outcomes Table:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nHeart failure with preserved ejection fraction\nN = 520,8851\nHeart failure with reduced ejection fraction\nN = 425,4051\np-value2\n\n\n\n\nDied during hospitalization\n15,395 (3.0%)\n16,390 (3.9%)\n&lt;0.001\n\n\nLength of stay (days)\n6.9 (7.1)\n7.5 (8.6)\n&lt;0.001\n\n\nInflation-adjusted total charge ($)\n74,877 (98,061)\n92,846 (156,520)\n&lt;0.001\n\n\n\n1 n (%); Mean (SD)\n\n\n2 Pearson’s X^2: Rao & Scott adjustment; Design-based KruskalWallis test\n\n\n\n\n\n\n\n\n\nMultivariable Logistic Regression:\n\nAll-Cause Mortality:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nHeart failure categories\n\n\n\n\n\n\n\n\n    Heart failure with preserved ejection fraction\n—\n—\n\n\n\n\n    Heart failure with reduced ejection fraction\n1.42\n1.35, 1.50\n&lt;0.001\n\n\nAge, y\n1.03\n1.02, 1.03\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n1.12\n1.06, 1.18\n&lt;0.001\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n1.01\n0.85, 1.20\n&gt;0.9\n\n\n    Black\n0.89\n0.83, 0.97\n0.004\n\n\n    Hispanic\n0.98\n0.89, 1.08\n0.7\n\n\n    Native American\n0.81\n0.55, 1.20\n0.3\n\n\n    Other\n0.95\n0.80, 1.14\n0.6\n\n\nElixhauser comorbidity index\n1.23\n1.21, 1.25\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n0.92\n0.86, 0.99\n0.022\n\n\n    $66,000 - $87,999\n0.89\n0.82, 0.96\n0.002\n\n\n    $88,000 or more\n0.89\n0.82, 0.97\n0.006\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n0.78\n0.69, 0.89\n&lt;0.001\n\n\n    Medicare\n0.80\n0.73, 0.88\n&lt;0.001\n\n\n    Other\n1.29\n1.06, 1.57\n0.009\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n1.12\n1.02, 1.22\n0.013\n\n\n    South\n0.97\n0.91, 1.05\n0.5\n\n\n    West\n0.96\n0.88, 1.05\n0.4\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.68\n0.60, 0.77\n&lt;0.001\n\n\nHyperlipidemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.71\n0.67, 0.75\n&lt;0.001\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.90\n0.84, 0.97\n0.006\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.91\n0.86, 0.97\n0.002\n\n\nChronic obstructive pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.83\n0.78, 0.88\n&lt;0.001\n\n\nValvular heart disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.88\n0.81, 0.95\n0.001\n\n\nDementia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.07\n0.99, 1.16\n0.090\n\n\nCancer\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.29\n1.18, 1.41\n&lt;0.001\n\n\nFluid and electrolyte imbalance\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n2.13\n2.00, 2.27\n&lt;0.001\n\n\nAtrial fibrillation\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.02\n0.96, 1.08\n0.6\n\n\nObesity\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.67\n0.63, 0.72\n&lt;0.001\n\n\nPresence of pacemaker\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.70\n0.64, 0.76\n&lt;0.001\n\n\nprevious MI\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.95\n0.88, 1.03\n0.2\n\n\nMalnutrition\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.59\n1.49, 1.70\n&lt;0.001\n\n\nPior cardiac surgery\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.82\n0.75, 0.89\n&lt;0.001\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio\n\n\n\n\n\n\n\n\n\n\n\nMultivariable Linear Regression:\n\nLength of Stay:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nBeta\n95% CI\np-value\n\n\n\n\nHeart failure categories\n\n\n\n\n\n\n\n\n    Heart failure with preserved ejection fraction\n—\n—\n\n\n\n\n    Heart failure with reduced ejection fraction\n0.49\n0.41, 0.56\n&lt;0.001\n\n\nAge, y\n-0.03\n-0.04, -0.03\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n0.35\n0.28, 0.42\n&lt;0.001\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n0.42\n0.03, 0.81\n0.036\n\n\n    Black\n0.17\n0.06, 0.28\n0.003\n\n\n    Hispanic\n0.18\n-0.03, 0.39\n0.089\n\n\n    Native American\n-0.20\n-0.65, 0.25\n0.4\n\n\n    Other\n0.81\n0.49, 1.1\n&lt;0.001\n\n\nElixhauser comorbidity index\n0.49\n0.46, 0.52\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n-0.07\n-0.18, 0.03\n0.2\n\n\n    $66,000 - $87,999\n0.06\n-0.05, 0.17\n0.3\n\n\n    $88,000 or more\n0.25\n0.11, 0.39\n&lt;0.001\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n0.27\n0.05, 0.48\n0.016\n\n\n    Medicare\n-0.14\n-0.28, -0.01\n0.040\n\n\n    Other\n-0.03\n-0.32, 0.27\n0.9\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n0.93\n0.75, 1.1\n&lt;0.001\n\n\n    South\n0.36\n0.22, 0.50\n&lt;0.001\n\n\n    West\n-0.35\n-0.53, -0.16\n&lt;0.001\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.22\n-0.36, -0.08\n0.002\n\n\nHyperlipidemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.60\n-0.67, -0.52\n&lt;0.001\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.03\n-0.14, 0.08\n0.6\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.06\n-0.02, 0.14\n0.12\n\n\nChronic obstructive pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.59\n-0.67, -0.51\n&lt;0.001\n\n\nValvular heart disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.18\n-0.29, -0.08\n&lt;0.001\n\n\nDementia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.34\n0.22, 0.46\n&lt;0.001\n\n\nCancer\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.27\n0.12, 0.42\n&lt;0.001\n\n\nFluid and electrolyte imbalance\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.9\n1.8, 2.0\n&lt;0.001\n\n\nAtrial fibrillation\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.09\n0.01, 0.16\n0.023\n\n\nObesity\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.03\n-0.12, 0.07\n0.6\n\n\nPresence of pacemaker\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.89\n-0.99, -0.79\n&lt;0.001\n\n\nprevious MI\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.59\n-0.68, -0.49\n&lt;0.001\n\n\nMalnutrition\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n3.2\n3.0, 3.4\n&lt;0.001\n\n\nPior cardiac surgery\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.72\n-0.80, -0.64\n&lt;0.001\n\n\n\nAbbreviation: CI = Confidence Interval\n\n\n\n\n\n\n\n\n\n\nInflation Adjusted Total Charge:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nBeta\n95% CI\np-value\n\n\n\n\nHeart failure categories\n\n\n\n\n\n\n\n\n    Heart failure with preserved ejection fraction\n—\n—\n\n\n\n\n    Heart failure with reduced ejection fraction\n13,146\n11,596, 14,695\n&lt;0.001\n\n\nAge, y\n-844\n-928, -759\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n6,150\n4,854, 7,446\n&lt;0.001\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n19,203\n12,594, 25,813\n&lt;0.001\n\n\n    Black\n624\n-1,435, 2,682\n0.6\n\n\n    Hispanic\n19,693\n15,195, 24,191\n&lt;0.001\n\n\n    Native American\n-15,218\n-22,737, -7,698\n&lt;0.001\n\n\n    Other\n32,202\n24,158, 40,246\n&lt;0.001\n\n\nElixhauser comorbidity index\n6,385\n5,753, 7,018\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n-172\n-2,062, 1,719\n0.9\n\n\n    $66,000 - $87,999\n2,749\n694, 4,803\n0.009\n\n\n    $88,000 or more\n10,892\n7,860, 13,923\n&lt;0.001\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n-8,080\n-11,850, -4,309\n&lt;0.001\n\n\n    Medicare\n-3,319\n-5,880, -758\n0.011\n\n\n    Other\n-1,758\n-7,235, 3,718\n0.5\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n21,917\n17,497, 26,336\n&lt;0.001\n\n\n    South\n11,956\n9,148, 14,764\n&lt;0.001\n\n\n    West\n40,510\n34,081, 46,939\n&lt;0.001\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-129\n-2,882, 2,625\n&gt;0.9\n\n\nHyperlipidemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-3,360\n-4,729, -1,990\n&lt;0.001\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n940\n-929, 2,810\n0.3\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n10,477\n9,051, 11,903\n&lt;0.001\n\n\nChronic obstructive pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-8,984\n-10,508, -7,460\n&lt;0.001\n\n\nValvular heart disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n13,275\n11,227, 15,323\n&lt;0.001\n\n\nDementia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-5,591\n-7,259, -3,923\n&lt;0.001\n\n\nCancer\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n2,870\n328, 5,413\n0.027\n\n\nFluid and electrolyte imbalance\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n21,886\n20,400, 23,372\n&lt;0.001\n\n\nAtrial fibrillation\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n2,191\n948, 3,435\n&lt;0.001\n\n\nObesity\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-2,970\n-4,697, -1,242\n&lt;0.001\n\n\nPresence of pacemaker\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-14,512\n-16,351, -12,674\n&lt;0.001\n\n\nprevious MI\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-12,237\n-13,912, -10,562\n&lt;0.001\n\n\nMalnutrition\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n40,491\n36,222, 44,760\n&lt;0.001\n\n\nPior cardiac surgery\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-15,682\n-17,105, -14,260\n&lt;0.001\n\n\n\nAbbreviation: CI = Confidence Interval"
  }
]